Trilogy Capital »

Dex shares owned by Trilogy Capital

Quarter-by-quarter ownership of Dex (DXCM) shares owned by Trilogy Capital from 13F filings

Historical chart of Trilogy Capital investment in Dex

Tip: Access up to 7 years of quarterly data

All positions including Dex held by Trilogy Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dex by Trilogy Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $460k 6.9k 67.04
2024-06-30 $1.8M 16k 113.38
2024-03-31 $471k 3.4k 138.70
2018-09-30 $6.0k 40 150.00
2018-03-31 $3.0k 35 85.71

More positions owned by Trilogy Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
First Tr Value Line Divid In SHS (FVD)
Vanguard Index Fds Total Stk Mkt (VTI)
Wisdomtree Tr Intl Qulty Div (IQDG)
Thor Finl Technologies Tr Low Volatility (THLV)
Schwab Strategic Tr Fundamental Us S (FNDA)
Wisdomtree Tr Yield Enhancd Us (AGGY)

View all positions for Trilogy Capital

Top funds holding Dex

Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
State Street Corporation
Baillie Gifford & Co
Sands Capital Management
Geode Capital Management
Capital World Investors
Jennison Associates
Nuveen Asset Management
Morgan Stanley
Jpmorgan Chase & Co
Invesco
Bank of New York Mellon

View all funds holding Dex